Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173472 | SCV000224590 | uncertain significance | not provided | 2016-08-29 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000173472 | SCV001059847 | likely benign | not provided | 2023-09-28 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003137703 | SCV003808240 | uncertain significance | Schaaf-Yang syndrome | 2022-12-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004639160 | SCV005131462 | likely benign | Inborn genetic diseases | 2024-03-30 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Laboratory of Diagnostic Genome Analysis, |
RCV000173472 | SCV001798861 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000173472 | SCV001927361 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000173472 | SCV001968992 | likely benign | not provided | no assertion criteria provided | clinical testing |